|
1
|
Gorelick PB: Stroke prevention therapy
beyond antithrombotics: unifying mechanisms in ischemic stroke
pathogenesis and implications for therapy: an invited review.
Stroke. 33:862–875. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Fisher M: Advances in stroke 2007:
introduction. Stroke. 39:250–251. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Honkaniemi J, Massa SM, Breckinridge M and
Sharp FR: Global ischemia induces apoptosis-associated genes in
hippocampus. Mol Brain Res. 42:79–88. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ruan YW, Ling GY, Zhang JL and Xu ZC:
Apoptosis in the rat striatum after transient forebrain ischemia
and the effects of ischemic severity. Brain Res. 982:228–240. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Liu C, Li J, Meng FY, et al:
Polysaccharides from the root of Angelica sinensis promotes
hematopoiesis and thrombopoiesis through the PI3K/AKT pathway. BMC
Complement Altern Med. 10:792010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Luo Y, Zhao HP, Zhang J, et al: Effect of
ferulic acid on learning and memory impairments of vascular
dementia rats and its mechanism of action. Yao Xue Xue Bao.
47:256–260. 2012.(In Chinese). PubMed/NCBI
|
|
7
|
Yi L, Liang Y, Wu H and Yuan D: The
analysis of Radix Angelicae Sinensis (Danggui). J Chromatogr A.
1216:1991–2001. 2009. View Article : Google Scholar
|
|
8
|
Ma ZC, Hong Q, Wang YG, et al: Effects of
ferulic acid on hematopoietic cell recovery in whole-body gamma
irradiated mice. Int J Radiat Biol. 87:499–505. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Yan S, Xie Y, Zhu B, Han Y and Guo W:
Effect comparison of different formulation of Dang-Gui-Bu-Xu-Tang
on myelosuppression mouse. Asian Pac J Trop Med. 4:556–559. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Cheng CY, Su SY, Tang NY, et al: Ferulic
acid provides neuroprotection against oxidative stress-related
apoptosis after cerebral ischemia/reperfusion injury by inhibiting
ICAM-1 mRNA expression in rats. Brain Res. 1209:136–150. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
van der Kooij MA, Groenendaal F, Kavelaars
A, Heijnen CJ and van Bel F: Neuroprotective properties and
mechanisms of erythropoietin in in vitro and in vivo experimental
models for hypoxia/ischemia. Brain Res Rev. 59:22–33. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
England TJ, Gibson CL and Bath PM:
Granulocyte-colony stimulating factor in experimental stroke and
its effects on infarct size and functional outcome: A systematic
review. Brain Res Rev. 62:71–82. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yamada M, Burke C, Colditz P, Johnson DW
and Gobe GC: Erythropoietin protects against apoptosis and
increases expression of non-neuronal cell markers in the
hypoxia-injured developing brain. J Pathol. 224:101–109. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Prass K, Scharff A, Ruscher K, et al:
Hypoxia-induced stroke tolerance in the mouse is mediated by
erythropoietin. Stroke. 34:1981–1986. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Sevimli S, Diederich K, Strecker JK, et
al: Endogenous brain protection by granulocyte-colony stimulating
factor after ischemic stroke. Exp Neurol. 217:328–335. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Jiang W, Fu F, Tian J, Zhu H and Hou J:
Curculigoside A attenuates experimental cerebral ischemia injury in
vitro and vivo. Neuroscience. 192:572–579. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Minematsu, Li L, Sotak CH, Davis MA and
Fisher M: Reversible focal ischemic injury demonstrated by
diffusion-weighted magnetic resonance imaging in rats. Stroke.
23:1304–1310. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kirino T: Delayed neuronal death in the
gerbil hippocampus following ischemia. Brain Res. 239:57–69. 1982.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Pulsinelli WA, Brierley JB and Plum F:
Temporal profile of neuronal damage in a model of transient
forebrain ischemia. Ann Neurol. 11:491–498. 1982. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Noguchi CT, Asavaritikrai P, Teng R and
Jia Y: Role of erythropoietin in the brain. Crit Rev Oncol Hematol.
64:159–171. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wu H, Liu X, Jaenisch R and Lodish HF:
Generation of committed erythroid BFU-E and CFU-E progenitors does
not require erythropoietin or the erythropoietin receptor. Cell.
83:59–67. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Tsai PT, Ohab JJ, Kertesz N, et al: A
critical role of erythropoietin receptor in neurogenesis and
post-stroke recovery. J Neurosci. 26:1269–1274. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Chikuma M, Masuda S, Kobayashi T, Nagao M
and Sasaki R: Tissue-specific regulation of erythropoietin
production in the murine kidney, brain, and uterus. Am J Physiol
Endocrinol Metab. 279:E1242–E1248. 2000.PubMed/NCBI
|
|
24
|
Yang Y and Rosenberg GA: Blood-brain
barrier breakdown in acute and chronic cerebrovascular disease.
Stroke. 42:3323–3328. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Sugiyama Y, Yagita Y, Oyama N, et al:
Granulocyte colony-stimulating factor enhances arteriogenesis and
ameliorates cerebral damage in a mouse model of ischemic stroke.
Stroke. 42:770–775. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Floel A, Warnecke T, Duning T, et al:
Granulocyte-colony stimulating factor (G-CSF) in stroke patients
with concomitant vascular disease--a randomized controlled trial.
PLoS One. 6:e197672011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Gibson CL, Bath PM and Murphy SP: G-CSF
administration is neuroprotective following transient cerebral
ischemia even in the absence of a functional NOS-2 gene. J Cereb
Blood Flow Metab. 30:739–743. 2010. View Article : Google Scholar : PubMed/NCBI
|
